Lilly J5J-OX-JZZA

cross-entity / Basket, Gastrointestinal tumors, Thoracic tumors
General, Pancreatic cancer, Colorectal cancer, Non-small cell lung cancer (NSCLC)
Follow-Up Treatment (Metastatic Disease)
The main purpose of this study is to assess safety & tolerability and antitumor activityof LY3962673 as monotherapy and in combination with other chemotherapy agents inparticipants with KRAS G12D-mutant advanced solid tumor types. The study is expected tolast approximately 5 years.
The main purpose of this study is to assess safety & tolerability and antitumor activity of LY3962673 as monotherapy and in combination with other chemotherapy agents in participants with KRAS G12D-mutant advanced solid tumor types. The study is expected to last approximately 5 years.